Wells Fargo’s GSK GSK Stock Holding History

Wells Fargo’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,000	Closed	-$812K	–	7128
2024 Q4	$812K	Buy	+24,000	New	+$864K	﹤0.01%	3856
2024 Q1	–	Sell	-5,800	Closed	-$215K	–	7590
2023 Q4	$215K	Buy	+5,800	New	+$208K	﹤0.01%	4425
2023 Q1	–	Sell	-30,000	Closed	-$1.05M	–	7722
2022 Q4	$1.05M	Buy	+30,000	New	+$999K	﹤0.01%	3211
2022 Q1	–	Sell	-6,960	Closed	-$384K	–	7337
2021 Q4	$384K	Buy	+6,960	New	+$362K	﹤0.01%	4874
2020 Q1	–	Sell	-20,000	Closed	-$125K	–	6422
2019 Q4	$125K	Hold	20,000	–	–	﹤0.01%	5195
2019 Q3	$46K	Hold	20,000	–	–	﹤0.01%	5582
2019 Q2	$23K	Hold	20,000	–	–	﹤0.01%	5755
2019 Q1	$48K	Buy	+20,000	New	+$999K	﹤0.01%	5332
2016 Q1	–	Sell	-24,160	Closed	-$10K	–	6286
2015 Q4	$10K	Buy	+24,160	New	+$1.23M	﹤0.01%	5730

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wells Fargo's GSK Position: Q2 2026 in Review

Wells Fargo reduced its GSK (GSK) stake by 3.1% in Q2 2026, selling an estimated $2.34M and leaving 1,361,227 shares worth $71.4M. The position accounts for 0.01% of the portfolio, ranked #833.

Wells Fargo first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $521M in Q2 2016. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Wells Fargo held 1,361,227 shares of GSK worth $71.4M as of Q2 2026.
Wells Fargo sold 44,271 GSK shares in Q2 2026, an estimated $2.34M.
GSK made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #833 holding.
Wells Fargo first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's GSK position peaked at $521M in Q2 2016.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.